Cbdmd engages leading biotech firm iontox to validate its patent pending superior broad spectrum blend

Charlotte, n.c.--(business wire)--cbdmd, inc. (nyse american: ycbd, ycbd.pr.a), one of the nation's leading and most highly trusted and recognized cannabidiol (cbd) brands, announced today that it has retained nationally recognized biotechnology company iontox (https://www.iontox.com), to validate the company's patent pending proprietary cannabinoid formulations. on july 9, 2020, cbdmd announced it had filed provisional patents on its novel formulations and delivery systems. this is the next st
YCBD Ratings Summary
YCBD Quant Ranking